Sign Up for Lp(a) Updates

For Public HCP This site is for US Health Care Professionals Only

At Novartis, we recognize the challenges that come with managing cardiovascular disease (CVD) and believe that Lp(a) testing can help to inform on overall CV risk for your patients with CVD and may also inform health care discussions. Sign up below to stay current on the latest developments.

Personal Information

*Required fields

First Name *

Last Name *

Specialty *

Email *

When was the last time you screened your patients for elevated Lp(a)? *

Address 1 (Optional)

Address 2 (Optional)

City *

State *

Zip Code *

Five digits only

Legal disclaimer: By clicking Submit, you understand that the information you provide will be used by Novartis Pharmaceuticals Corporation (NPC) for marketing purposes, in accordance with the NPC Privacy Policy and Terms of Use.

Submit

Reference: 1. Koschinsky ML, et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18(3):e308-e319.